Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hamajima

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|June 1, 1992
[Attributable risk percent under an effect modifier and legal causality]N Hamajima
Expert Review of Molecular Diagnostics|March 21, 2002
PCR-CTPP: a new genotyping technique in the era of genetic epidemiologyN Hamajima
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 1, 1992
["Karoshi" and causal relationships]N Hamajima
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1995
[Status quo and problems in phase III trials: view of a trialist]N Hamajima
Nihon Gan Chiryo Gakkai Shi|October 20, 1988
[Application of logistic model to clinical research]N Hamajima
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Reappraisal of Zelen's method in randomized controlled trials]N Hamajima
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 1, 1991
[Epidemiology and civil trials]N Hamajima
Journal of Epidemiology|March 1, 1997
Patients' views on reference to clinical dataN Hamajima, K Tajima
Gan|July 1, 1984
Prediction of male lung cancer mortality in Japan based on birth cohort analysisN Hamajima, K Aoki
Ryoikibetsu Shokogun Shirizu|May 20, 1998
[Dihydropyrimidinase deficiency (dihydropyrimidinuria)]N Hamajima, Y Wada
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|June 1, 1992
[Attributable risk percent under an effect modifier and legal causality]N Hamajima
Expert Review of Molecular Diagnostics|March 21, 2002
PCR-CTPP: a new genotyping technique in the era of genetic epidemiologyN Hamajima
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 1, 1992
["Karoshi" and causal relationships]N Hamajima
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1995
[Status quo and problems in phase III trials: view of a trialist]N Hamajima
Nihon Gan Chiryo Gakkai Shi|October 20, 1988
[Application of logistic model to clinical research]N Hamajima
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Reappraisal of Zelen's method in randomized controlled trials]N Hamajima
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 1, 1991
[Epidemiology and civil trials]N Hamajima
Journal of Epidemiology|March 1, 1997
Patients' views on reference to clinical dataN Hamajima, K Tajima
Gan|July 1, 1984
Prediction of male lung cancer mortality in Japan based on birth cohort analysisN Hamajima, K Aoki
Ryoikibetsu Shokogun Shirizu|May 20, 1998
[Dihydropyrimidinase deficiency (dihydropyrimidinuria)]N Hamajima, Y Wada
Pageof 17